Avior Wealth Management LLC Purchases 101 Shares of Teleflex Incorporated (NYSE:TFX)

Avior Wealth Management LLC increased its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 190.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 154 shares of the medical technology company’s stock after acquiring an additional 101 shares during the period. Avior Wealth Management LLC’s holdings in Teleflex were worth $38,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cooke & Bieler LP raised its stake in shares of Teleflex by 23.3% in the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock worth $191,989,000 after acquiring an additional 172,335 shares during the last quarter. TD Asset Management Inc raised its position in Teleflex by 12.0% in the 2nd quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company’s stock worth $95,928,000 after purchasing an additional 48,832 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in Teleflex by 6.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 425,647 shares of the medical technology company’s stock worth $89,526,000 after buying an additional 26,325 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Teleflex by 4.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 398,175 shares of the medical technology company’s stock valued at $83,741,000 after buying an additional 15,992 shares during the last quarter. Finally, Point72 Asset Management L.P. boosted its position in Teleflex by 564.3% in the 2nd quarter. Point72 Asset Management L.P. now owns 310,484 shares of the medical technology company’s stock valued at $65,304,000 after buying an additional 263,743 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Up 1.5 %

Shares of NYSE TFX opened at $194.60 on Tuesday. Teleflex Incorporated has a 52-week low of $185.66 and a 52-week high of $257.85. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock has a market cap of $9.04 billion, a P/E ratio of 38.69, a P/E/G ratio of 1.96 and a beta of 1.18. The firm has a 50 day moving average price of $223.96 and a 200 day moving average price of $222.96.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.64 EPS. Analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.70%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on TFX. Stephens upped their price target on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. Royal Bank of Canada dropped their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Mizuho reduced their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Truist Financial reissued a “hold” rating and set a $227.00 price target (down from $255.00) on shares of Teleflex in a research note on Monday, November 4th. Finally, Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Friday, November 1st. Four analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $259.25.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.